International Symposium Review
Submitted by Jeff Dubois, Conference Chair
The 24th International Sympo
sium welcomed 253 attendees to
Prague, making it the 3rd highest
attended symposium ever behind
the 350 Boston (2010) and the
308 in Barcelona (2008).
33 Countries were represented
and those traveling the farthest
distance came from New Zealand,
Australia, and Japan.
The country with the highest rep
resentation was the US with 67
attendees followed by the Nether
lands with 39 attendees.
Regarding Abstracts/Posters, 90
were submitted, 82 accepted,
and 74 displayed.
- Glucose meter performance
criteria for moderate levels of
glycemic control estimated by
error simulation of modeling.
Brad Karon, MD, PhD, Mayo
Clinic, Rochester, MN
- Rapid test quantum Blue®
faecal calprotectin as pre
dictor of relapse in patients
under maintenance treatment
with Infliximab®. Manuel
Otero Santiago, University of
Santiago Hospital, Spain.
There were 14 invited speakers plus 3 abstracts were selected for
both oral and poster presentation. Continuing Medical Education and
Accent Credits were provided. Conference Proceedings was organized
into the 5 sessions shown in the table below.
||Why are there differences in
reported benefits and outcomes
with tight glycemic protocols in
critical care patients - A debate?
||Martha Lyon, PhD, Alberta
Children's Hospital, CN
||Sources and Prevention of Errors
in Point of Care Testing
||Robbert Slingerland, Isala
Klinieken, The Netherlands
||Point-of-Care Testing Beyond the
||Ian Watson, PhD, Univ Hos
pital Aintree, Liverpool, UK
||Developing Effective Strategies
to Achieve Quality POCT Results
||Linda Sandhaus, MD, Uni
versity Hospitals of Cleve
||New Technologies in Point-of-
||Larry Crolla, PhD, Alexian
Brothers Medical Center, Elk
Grove Village, IL